KROS short interest
Keros Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,149,418 |
|---|---|
| Change vs prior report | -193,202 (-14.4%) |
| Change over six months | -23.1% |
| Days to cover | 5.61 (sector: 3.78) |
| Average daily volume | 205,020 |
| Rank in Healthcare | #362 of 922 by days to cover |
KROS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,149,418 | -14.4% | 5.61 | 205,020 |
| 2026-09-15 | 1,342,620 | +15.2% | 9.13 | 147,052 |
| 2026-08-31 | 1,165,086 | +1.4% | 6.09 | 191,301 |
| 2026-08-14 | 1,148,951 | +16.6% | 4.73 | 242,951 |
| 2026-07-31 | 985,590 | -6.9% | 5.92 | 166,397 |
| 2026-07-15 | 1,058,882 | +3.2% | 4.08 | 259,282 |
| 2026-06-30 | 1,026,323 | -27.1% | 2.54 | 403,759 |
| 2026-06-15 | 1,407,890 | -6.7% | 6.60 | 213,268 |
| 2026-05-29 | 1,508,786 | -11.5% | 4.54 | 332,403 |
| 2026-05-15 | 1,704,362 | +20.4% | 4.65 | 366,493 |
| 2026-04-30 | 1,415,972 | +1.2% | 5.36 | 263,969 |
| 2026-04-15 | 1,399,759 | -6.4% | 3.47 | 403,815 |
| 2026-03-31 | 1,494,814 | -24.9% | 2.63 | 568,956 |
| 2026-03-13 | 1,989,399 | -2.1% | 3.52 | 565,163 |
| 2026-02-27 | 2,031,197 | -14.8% | 6.60 | 307,757 |
| 2026-02-13 | 2,383,895 | +4.7% | 8.82 | 270,381 |
| 2026-01-30 | 2,277,105 | -2.9% | 8.84 | 257,538 |
| 2026-01-15 | 2,345,217 | -5.6% | 5.25 | 446,480 |
| 2025-12-31 | 2,484,362 | -7.7% | 4.58 | 541,908 |
| 2025-12-15 | 2,692,419 | -16.6% | 3.04 | 885,542 |
| 2025-11-28 | 3,228,958 | -52.4% | 2.40 | 1,343,425 |
| 2025-11-14 | 6,781,420 | +15.7% | 5.39 | 1,258,629 |
| 2025-10-31 | 5,862,479 | +53.5% | 5.41 | 1,084,229 |
| 2025-10-15 | 3,817,848 | -1.3% | 3.81 | 1,001,572 |
| 2025-09-30 | 3,867,988 | -16.2% | 11.98 | 322,739 |
import finzdata as yf
yf.Ticker("KROS").short_interest # every report since 2017
yf.Client().short_interest(["KROS"], start="2018-01-01")Healthcare short interest · KROS price history · Who owns KROS · All short interest